(Q35531714)

8 August 2017

title

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ (English)

1 reference

8 August 2017

1 reference

10

Funda Meric-Bernstam

1 reference

8 August 2017

11

Gabriel N Hortobagyi

1 reference

8 August 2017

Soley Bayraktar

1

1 reference

8 August 2017

Nisreen Elsayegh

2

1 reference

8 August 2017

Angelica M Gutierrez Barrera

3

1 reference

8 August 2017

Heather Lin

4

1 reference

8 August 2017

Henry Kuerer

5

1 reference

8 August 2017

Tunc Tasbas

6

1 reference

8 August 2017

Kimberly I Muse

7

1 reference

8 August 2017

Kaylene Ready

8

1 reference

8 August 2017

Jennifer Litton

9

1 reference

8 August 2017

Constance T Albarracin

12

1 reference

8 August 2017

Banu Arun

13

1 reference

8 August 2017

language of work or name

English

0 references

publication date

25 August 2011

1 reference

8 August 2017

1 reference

8 August 2017

volume

118

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

1515-1522

1 reference

Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

The natural history of ductal carcinoma in situ of the breast: a review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

Identification of the breast cancer susceptibility gene BRCA2

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

12 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26428

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26428

Ductal carcinoma in situ in BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26428

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26428

BRCA mutations in women with ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26428

High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407692

High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer

26 September 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26428

Epithelial lesions in prophylactic mastectomy specimens from women withBRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26428

Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001

21 January 2018

1 reference

12 December 2020

In-situ breast cancer and BRCA1

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ

1 reference

12 December 2020

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO

1 reference

12 December 2020

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium

1 reference

12 December 2020

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.26428

1 reference

8 August 2017

1 reference

8 August 2017

1 reference